Le nostre pubblicazioni scientifiche Archives - Alanonlus

May 01
0



https://www.frontiersin.org/articles/10.3389/fnmol.2016.00031/full
May 17
0

Pubblicazioni Scientifiche Negli Ultimi 10 Anni

Posted by | Le nostre pubblicazioni scientifiche | No Comments
  1. Familial Alzheimer’s disease sustained by presenilin 2 mutations: Systematic review of literature and genotype-phenotype correlation.

    Canevelli M, Piscopo P, Talarico G, Vanacore N, Blasimme A, Crestini A, Tosto G, Troili F, Lenzi GL, Confaloni A, Bruno G.
    Neurosci Biobehav Rev. 2014

  2. Thapsigargin affects presenilin-2 but not presenilin-1 regulation in SK-N-BE cells.

    Rivabene R, Visentin S, Piscopo P, Nuccio CD, Crestini A, Svetoni F, Rosa P, Confaloni A.
    Exp Biol Med. 2014; 239 (2):213-24.

  3. Autosomal dominant frontotemporal lobar degeneration due to the C9ORF72 hexanucleotide repeat expansion: late-onset psychotic clinical presentation.

    Galimberti D, Fenoglio C, Serpente M, Villa C, Bonsi R, Arighi A, Fumagalli GG, Del Bo R, Bruni AC, Anfossi M, Clodomiro A, Cupidi C, Nacmias B, Sorbi S, Piaceri I, Bagnoli S, Bessi V, Marcone A, Cerami C, Cappa SF, Filippi M, Agosta F, Magnani G, Comi G, Franceschi M, Rainero I, Giordana MT, Rubino E, Ferrero P, Rogaeva E, Xi Z, Confaloni A, Piscopo P, Bruno G, Talarico G, Cagnin A, Clerici F, Dell’Osso B, Comi GP, Altamura AC, Mariani C, Scarpini E.
    Biol Psychiatry. 2013;74 (5) :384-91.

  4. Gender differences in Parkinson’s disease: focus on plasma α-synuclein.

    Caranci G, Piscopo P, Rivabene R, Traficante A, Riozzi B, Castellano AE, Ruggieri S, Vanacore N, Confaloni A.
    J Neural Transm. 2013;120 (8): 1209-15.

  5. Pharmacogenomics in Alzheimer’s disease: a genome-wide association study of response to cholinesterase inhibitors.

    Martinelli-Boneschi F, Giacalone G, Magnani G, Biella G, Coppi E, Santangelo R, Brambilla P, Esposito F, Lupoli S, Clerici F, Benussi L, Ghidoni R, Galimberti D, Squitti R, Confaloni A, Bruno G, Pichler S, Mayhaus M, Riemenschneider M, Mariani C, Comi G, Scarpini E, Binetti G, Forloni G, Franceschi M, Albani D.
    Neurobiol Aging.2013; 34 (6):1711.e7-13.

  6. Gender effects on plasma PGRN levels in patients with Alzheimer’s disease: a preliminary study.

    Piscopo P, Rivabene R, Galimberti D, Crestini A, Talarico G, Vanacore N, Scarpini E, Bruno G, Confaloni A.
    J Alzheimers Dis. 2013; 35 (2): 313-8.

  7. Sex effect on presenilins expression in post-natal rat brain.

    Paola Piscopo, Sonia Canterini, Valentina Carletti, Paolo Rosa, Alessio Crestini, Maria Teresa Fiorenza, Annamaria Confaloni
    Advances in Bioscience and Biotechnology, 2013,4,1086-1094.

  8. Increased levels of acute-phase inflammatory proteins in plasma of patients with sporadic CJD.

    Fratini F, Principe S, Puopolo M, Ladogana A, Poleggi A, Piscopo P, Bruno G, Castrechini S, Pascone R, Confaloni A, Minghetti L, Cardone F, Pocchiari M, Crescenzi M.
    Neurology. 2012;79 (10):1012-8.

  9. Replication Study to Confirm the Role of CYP2D6 Polymorphism rs1080985 on Donepezil Efficacy in Alzheimer’s Disease Patients.

    Albani D, Boneschi FM, Biella G, Giacalone G, Lupoli S, Clerici F, Benussi L, Ghidoni R, Galimberti D, Squitti R, Mariani S, Confaloni A, Bruno G, Mariani C, Scarpini E, Binetti G, Magnani G, Franceschi M, Forloni G.
    J Alzheimers Dis. 2012;30 (4) :745-9..

  10. Presenilin 2 mutation R71W in an Italian early-onset sporadic Alzheimer’s disease case.

    Piscopo P, Talarico G, Malvezzi-Campeggi L, Crestini A, Rivabene R, Gasparini M, Tosto G, Vanacore N, Lenzi GL, Bruno G, Confaloni A.
    J Neurol. 2011;258 (11): 2043-7.

  11. Altered oxidative stress profile in the cortex of mice fed an enriched branched-chain amino acids diet:possible link with amyotrophic lateral sclerosis?

    Piscopo P, Crestini A, Adduci A, Ferrante A, Massari M, Popoli P, Vanacore N, Confaloni A.
    J Neurosci Res. 2011; 89 (8):1276-83.

  12. Rosuvastatin and thapsigargin modulate γ-secretase gene expression and APP processing in a human neuroglioma model.

    Crestini A, Piscopo P, Iazeolla M, Albani D, Rivabene R, Forloni G, Confaloni A.
    J Mol Neurosci. 2011;43 (3):461-9.

  13. Hypoxia induces up-regulation of progranulin in neuroblastoma cell lines.

    Piscopo P, Rivabene R, Adduci A, Mallozzi C, Malvezzi-Campeggi L, Crestini A, Confaloni A.
    Neurochem Int. 2010; 57 (8): 893-8.

  14. The London APP mutation (Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer’s disease.

    Talarico G, Piscopo P, Gasparini M, Salati E, Pignatelli M, Pietracupa S, Malvezzi-Campeggi L, Crestini A, Boschi S, Lenzi GL, Confaloni A, Bruno G.
    Dement Geriatr Cogn Disord. 2010;29 (6):484-90.

  15. A novel mutation in the predicted TM3 domain of the PSEN2 gene in an Italian pedigree with atypical Alzheimer’s disease.

    P. Piscopo, G. Talarico, A. Crestini, M. Gasparini, L. Malvezzi-Campeggi, E. Piacentini, G. L. Lenzi, G. Bruno and A. Confaloni.
    J Alzheimers Dis. 2010;20 (1):43-7.

  16. Gene Expression Profiles of APP and BACE1 in Tg SOD1G93A Cortical Cells.

    O. Spadoni, A. Crestini, P. Piscopo, L. Malvezzi-Campeggi, I. Carunchio, M. Pieri, C. Zona, A. Confaloni.
    Cell Mol Neurobiol (2009) 29:635–641

  17. A Novel PSEN2 mutation associated with a peculiar phenotype.

    P. Piscopo, G. Marcon, M.R. Piras, A Crestini, L. Malvezzi Campeggi, E. Deiana, R. Cherchi, F. Tanda, A. Deplano, N. Vanacore, F. Tagliavini, M. Pocchiari, G. Giaccone and A. Confaloni.
    Neurology (2008);70 (17):1549-54.

  18. Altered expression of cyclooxygenase-2, presenilins and oxygen radical scavenging enzymes in a rat model of global perinatal asphyxia.

    Piscopo P, Bernardo A, Calamandrei G, Venerosi A, Valanzano A, Bianchi D, Confaloni A, Minghetti L.
    Exp Neurol. (2008);209 (1):192-8;

  19. gamma-Secretase is differentially modulated by alterations of homocysteine cycle in neuroblastoma and glioblastoma cells.

    Fuso A, Cavallaro RA, Zampelli A, D’Anselmi F, Piscopo P, Confaloni A, Scarpa S.
    J Alzheimers Dis. (2007);11(3):275-90.

  20. Presenilin-1 mutation E318G and familial Alzheimer’s disease in the Italian population.

    Albani D, Roiter I, Artuso V, Batelli S, Prato F, Pesaresi M, Galimberti D, Scarpini E, Bruni A, Franceschi M, Piras MR, Confaloni A, Forloni G.
    Neurobiol Aging. (2007);28 (11):1682-8.

  21. Changes in cholesterol metabolism are associated with Presenilin 1 and Presenilin 2 gene regulation in SK-N-BE.

    Crestini A, Napolitano M, Piscopo P, Confaloni A, Bravo E.
    J Mol Neurosci. (2006);30 (3):311-22.

  22. Cognitive deficits in familial Alzheimer’s disease associated with M239V mutation of presenilin 2.

    Giovagnoli AR, Marcon G, Giaccone G, Confaloni A, Tagliavini F.
    Dement Geriatr Cogn Disord. (2006);22 (3):238-43.

  23. Genetic study of Sardinian patients with Alzheimer’s disease.

    Piscopo P, Manfredi A, Malvezzi-Campeggi L, Crestini A, Spadoni O, Cherchi R, Deiana E, Piras MR, Confaloni A.
    Neurosci Lett. (2006); 398 (1-2):124-8.

  24. PEN-2 gene mutation in a familial Alzheimer’s disease case.

    Sala Frigerio C, Piscopo P, Calabrese E, Crestini A, Malvezzi Campeggi L, Civita di Fava R, Fogliarino S, Albani D, Marcon G, Cherchi R, Piras R, Forloni G, Confaloni A.
    J Neurol.(2005); 252 (9):1033-6.

  25. Rat nicastrin gene: cDNA isolation, mRNA variants and expression pattern analysis.

    Confaloni A, Crestini A, Albani D, Piscopo P, Malvezzi Campeggi L, Terreni L, Tartaglia M, Forloni G.
    Brain Res Mol Brain Res. (2005);136 (1-2): 12-22.